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Na,K-ATPase is a protein ubiquitously expressed in the plasma membrane of all animal
cells and vitally essential for their functions. A specialized functional diversity of the
Na,K-ATPase isozymes is provided by molecular heterogeneity, distinct subcellular
localizations, and functional interactions with molecular environment. Studies over
the last decades clearly demonstrated complex and isoform-specific reciprocal
functional interactions between the Na,K-ATPase and neighboring proteins and lipids.
These interactions are enabled by a spatially restricted ion homeostasis, direct
protein-protein/lipid interactions, and protein kinase signaling pathways. In addition to
its “classical” function in ion translocation, the Na,K-ATPase is now considered as
one of the most important signaling molecules in neuronal, epithelial, skeletal, cardiac
and vascular tissues. Accordingly, the Na,K-ATPase forms specialized sub-cellular
multimolecular microdomains which act as receptors to circulating endogenous
cardiotonic steroids (CTS) triggering a number of signaling pathways. Changes in these
endogenous cardiotonic steroid levels and initiated signaling responses have significant
adaptive values for tissues and whole organisms under numerous physiological and
pathophysiological conditions. This review discusses recent progress in the studies of
functional interactions between the Na,K-ATPase and molecular microenvironment, the
Na,K-ATPase-dependent signaling pathways and their significance for diversity of cell
function.
Keywords: Na, K-ATPase molecular heterogeneity, subcellular microdomains, cardiotonic steroids, signaling
pathways, blood pressure, cell survival
INTRODUCTION
The Na,K-ATPase is “an enzyme of life” because of its essential role in cell life and death.
The Na,K-ATPase is an ubiquitous membrane transport protein responsible for establishing and
maintaining high K+ and low Na+ concentrations in the cytoplasm (Skou, 1957). This ion
translocation activity underlies the resting membrane potential, excitability, and provides the
driving force for secondary ion transport. Ionic homeostasis maintained by the Na,K-ATPase
is critical for numerous cellular functions and processes, including cell growth, differentiation,
migration, contraction, secretion, and volume regulation. The list of these cellular tasks
is constantly growing. Na,K-ATPase varies in its molecular organization, exhibiting distinct
properties, and localization that suggests a specialized functional diversity (Sweadner, 1989;
Blanco and Mercer, 1998; Mobasheri et al., 2000; Geering, 2008; Li and Langhans, 2015).
Our current knowledge suggests highly complex and isoform-specific reciprocal functional
interactions and signaling between the Na,K-ATPase and neighboring proteins and lipids.
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Na,K-ATPase is able to form multimolecular complexes
where it participates as scaffolding protein in formation of
specialized sub-cellular microdomains or microcompartments
(Xie and Askari, 2002; Schoner and Scheiner-Bobis,
2007; Rajasekaran et al., 2008; Reinhard et al., 2013;
Krivoi, 2014).
The extracellular loops of Na,K-ATPase catalytic α subunit
form unique highly specific binding site for cardiotonic steroids
(CTS) and their circulating endogenous analogs (Bagrov et al.,
2009; Ogawa et al., 2009; Lingrel, 2010; Laursen et al., 2013).
Physiological significance of CTS binding site is still under
debate. It remains uncertain whether it affects numerous
cellular functions by inhibiting enzymatic activity that leads to
modulation of ion homeostasis or by conformational changes of
the α subunit and initiation of a signal transduction. The role of
the Na,K-ATPase CTS binding site suggests its involvement in
regulation of diverse cellular functions, including synaptic and
neural processes (Lichtstein and Rosen, 2001; Goldstein et al.,
2006, 2011; Song et al., 2013), cell survival and neuroprotection
(Golden and Martin, 2006; Dvela et al., 2012; Sibarov et al.,
2012; Dvela-Levitt et al., 2014), muscle contraction (Dostanic-
Larson et al., 2005; Radzyukevich et al., 2009), intercellular
communications (Matchkov et al., 2007, 2012), and gene
expression (Xiao et al., 2002; Kulikov et al., 2007; Orlov and
Hamet, 2015; Blanco and Venugopal, 2016). Knowledge on
the role of Na,K-ATPase and endogenous CTS in intracellular
signaling opens new perspectives for modulation of cell function
under normal and pathological conditions. The present review
focuses on the isoform-specific functions of the Na,K-ATPase
and specialized interactions with molecular environment which
underlie a variety of the Na,K-ATPase-dependent regulatory
mechanisms.
MOLECULAR DIVERSITY OF Na,K-ATPase
A molecular heterogeneity of the same functional protein is one
of the well-documented principles in cell biology (Le Novère
et al., 2002; Massoulié, 2002; Drabkina and Krivoi, 2004; Markov
et al., 2015). It includes the heterogeneity in structure and
diversity in function of the Na,K-ATPase (Sweadner, 1989;
Blanco and Mercer, 1998; Mobasheri et al., 2000; Geering, 2008;
Li and Langhans, 2015).
Na,K-ATPase is a P-type ATPase, a protein vital for cellular
function and ubiquitously expressed in the plasma membrane
of all animal cells. An enzymatic activity of the Na,K-ATPase
provides an electrical excitability and driving force for many
other transmembrane transports. An ion translocation, described
by Post-Albers reaction, suggests cyclic transitions of the Na,K-
ATPase between two principal conformational states, E1 and
E2 which selectively bind three Na+ ions or two K+ ions,
respectively. Each cycle uses the energy from hydrolysis of one
ATP molecule. This active ion transport generates an additional
negative (electrogenic) membrane potential due to the net
outward transfer of one positive charge per transport cycle
(Sperelakis, 2001; Dobretsov and Stimers, 2005).
Minimal functional unit of the Na,K-ATPase is a heteromeric
complex consisting of a large α catalytic (∼110 kDa)
and smaller β glycoprotein (∼31.5 kDa) subunits. The α
subunit is responsible for ion transport. This subunit has 10
transmembrane domains which contain binding sites for Na+
ions on the extracellular loops and for K+ ions and ATP on the
intracellular loops (Blanco and Mercer, 1998; Mobasheri et al.,
2000). The β subunit is a single-transmembrane protein which
is required for enzymatic activity and modulates the enzyme
affinity to Na+ and K+ ions. It also functions as chaperone
targeting the α subunit to the plasma membrane and plays
an important role in cell adhesion (Liu and Askari, 2006; Liu
et al., 2011; Tokhtaeva et al., 2012). In some tissues a small
single-transmembrane protein of FXYD family (∼7 kDa) has
been found to be associated with the functional Na,K-ATPase α/β
complexes and known to modulate enzymatic activity (Sweadner
and Rael, 2000; Garty and Karlish, 2006; Geering, 2008; Pavlovic
et al., 2013; Arystarkhova, 2016). Four isoforms of the α subunit
and three isoforms of the β subunit are expressed in a cell- and
tissue-specific manner providing wide molecular diversity of the
Na,K-ATPase (Blanco and Mercer, 1998; Mobasheri et al., 2000;
Mijatovic et al., 2007; Li and Langhans, 2015). Seven proteins of
the FXYD family provide additional diversity to these assemblies
(Sweadner and Rael, 2000; Garty and Karlish, 2006; Geering,
2008; Pavlovic et al., 2013; Arystarkhova, 2016).
It is generally accepted that the ubiquitous α1 isoform plays
main “housekeeping” role while the other isoforms are expressed
in a cell-specific manner. In some tissues, e.g., erythrocytes,
kidney epithelia and liver, the α1 isoform is the only isoform
expressed, while the majority of other cell types co-expressed
other α isoforms serving additional regulatory functions that
often are poorly understood. Thus, the α2 isoform is principally
expressed in skeletal, cardiac and smooth muscles as well as in
glial cells while the α3 isoform is characteristic for neuronal
tissues (Blanco and Mercer, 1998; Mobasheri et al., 2000;
Dobretsov and Stimers, 2005; Krivoi, 2012; Li and Langhans,
2015). The α4 isoform has been found only in testis (Woo et al.,
2000).
CARDIOTONIC STEROID BINDING SITE OF
THE Na,K-ATPase AND ENDOGENOUS
INHIBITORS
All known Na,K-ATPase isozymes contain specific receptor for
inhibitors collectively known as CTS—compounds characterized
by a steroid nucleus. Several plants are shown to contain
CTS such as ouabain, digoxin, digitoxin, and proscillaridin A
(Mijatovic et al., 2007; Bagrov et al., 2009). CTS are also found in
animal species and occur mainly in toads, e.g., marinobufagenin
isolated from the skin of Bufo marinus (Bagrov et al., 2009). CTS
are lethal in high concentrations while in low concentrations they
(particularly, digoxin, and digitoxin) are widely used as positive
inotropic agents (Gheorghiade et al., 2004).
The specific binding site for CTS is formed by an extracellular
region between M1–M2, M5–M6, and M7–M8 transmembrane
domains of the Na,K-ATPase α subunit (Mijatovic et al., 2007;
Bagrov et al., 2009; Ogawa et al., 2009; Lingrel, 2010; Sandtner
et al., 2011; Laursen et al., 2013). CTS molecules bind and
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stabilize the Na,K-ATPase in E2 conformation inhibiting the
transport activity of the enzyme. Isoforms of the α subunit Na,K-
ATPase differ in their sensitivity to ouabain, a CTS found in
plants and animal tissues, with greatest difference in rodents. In
rodents, the α1 isozyme is relatively resistant to ouabain (the
IC50 values for inhibition of the Na,K-ATPase are between tens
to hundreds micromolar), while the α2, α3, and α4 isozymes
are two-four orders of magnitude more sensitive (Dobretsov
and Stimers, 2005; Lingrel, 2010). The sensitivity to ouabain
is determined by two amino acids at the positions 111 and
122 in transmembrane domains M1–M2. Genetic manipulations
substituting these amino acids in mice produced mice with
various combinations of the α1 and α2 isozyme sensitivities to
ouabain and to study the physiological role of the CTS binding
site (Lingrel, 2010).
Knowledge on the Na,K-ATPase sensitivity to ouabain and
other CTS is of a great importance. Notably, apart from rodents,
the α1 Na,K-ATPase isozyme in rabbit, pig, dog, sheep, guinea
pig, and human is relatively sensitive to ouabain (see for
review: Blanco and Mercer, 1998; Dobretsov and Stimers, 2005;
Mijatovic et al., 2007; Lingrel, 2010). Some studies in humans
showed high and similar affinity of α1, α2, and α3 isozymes for
cardiac glycosides with ouabain binding constants in nanomolar
concentration range (Wang et al., 2001). Moderate selectivity
between human α-subunit isoforms was also shown. By contrast,
digoxin and a number of other CTS demonstrated lower affinities
and more significant selectivity compared to ouabain (Crambert
et al., 2000; Katz et al., 2010; Cherniavsky Lev et al., 2015). The
reasons for this differentiated selectivity remain to be elucidated.
The presence of an endogenous ouabain-like compounds was
suggested almost 40 years ago (Haddy and Overbeck, 1976;
Blaustein, 1977) and endogenous ouabain was later purified
from human blood plasma (Hamlyn et al., 1991). Several
facts point toward ouabain being a hormone synthesized and
secreted by the adrenal cortex. First, ouabain has been found
in high concentrations in the adrenal cortex (Hamlyn et al.,
1991; Blaustein, 1993; Hamlyn, 1998; Li et al., 1998). Second,
bovine adrenocortical cells have been shown to secrete ouabain
in amounts greater than their storage capacity under in vitro
conditions (Laredo et al., 1994, 1995). Third, the concentration
of ouabain in adrenal venous blood is significantly higher than in
arterial plasma (Boulanger et al., 1993). Moreover, adrenal cortex
tumors have been characterized by overproduction and secretion
of ouabain (Komiyama et al., 1999). Consistently, administration
of anti-ouabain antibodies to rats produces adrenal cortex
enlargement, further implicating the adrenal gland as a source of
ouabain (Nesher et al., 2009).
Ouabain is believed to be synthesized in zona glomerulosa
cells of the adrenal cortex, as other adrenal steroids and
the synthesis involves a rate-limiting side chain cleavage
of cholesterol (Laredo et al., 1995). Hydroxycholesterol,
pregnenalone, and progesterone have been shown to increase
the secretion of ouabain, possibly acting as precursors in its
biosynthetic pathway (Hamlyn et al., 1998; Lichtstein et al.,
1998). Moreover, the synthesis of ouabain follows a similar
pathway as aldosterone (Hamlyn et al., 2003). However, the exact
mechanisms and precursors involved in ouabain biosynthesis are
still unclear. Also hypothalamus has been suggested to synthesize
ouabain or ouabain-like compound(s) (Li et al., 1998) which may
play a central neuromodulatory role leading to excitation of the
central sympathoexcitatory pathways (Blaustein et al., 2012).
In addition to ouabain, structurally similar digoxin,
marinobufogenin and a number of other digitalis-like
compounds were further identified endogenously (Lichtstein
and Rosen, 2001; Schoner and Scheiner-Bobis, 2007; Bagrov
et al., 2009). Endogenous ouabain and marinobufagenin are well-
studied. Their concentration in blood plasma and cerebro-spinal
fluid of mammals varies at subnanomolar range. Elevated level
of endogenous CTS has been found under physiological (e.g.,
strenuous exercise, newborn infants) and pathophysiological
(e.g., congestive heart failure, hypertension, chronic renal failure,
preeclampsia, and affective disorders) conditions suggesting
the role for these compounds for modulation of body function
and in pathologies (Lichtstein and Rosen, 2001; Schoner, 2002;
Dobretsov and Stimers, 2005; Bagrov et al., 2009).
SUBCELLULAR
COMPARTMENTALIZATION OF THE
Na,K-ATPase FUNCTION
Subcellular compartmentalization is one of the basic principles
of intracellular organization (Saks et al., 2009). Particularly
diffusion restriction between cytosolic bulk and spatially
limited submembrane space is enabled in local microdomains.
In cardiac cell, the α1 Na,K-ATPase isozyme is relatively
uniformly distributed between external sarcolemma and T-
tubular membranes, while the α2 isozyme is concentrated in T-
tubules with a preferential localization close to the junctional
sarcoplasmic reticulum (SR) (Shattock et al., 2015). In addition,
the Na,K-ATPase forms large membrane macromolecular
complexes with Na+,Ca2+ exchanger (NCX), and ATP-sensitive
K+ (KATP) channels, coordinated by ankyrin-B (Li et al.,
2010). The KATP channels are densely expressed at the places
where T-tubules create membrane junctions with the SR
(Alekseev et al., 2012). Being co-localized with the Na,K-
ATPase, KATP channels open in response to increased energy
utilization accompanied by the local ATP depletion within a
diffusion-restricted submembrane space. This adjusts cardiac cell
electrogenesis and excitability across a wide range of workloads
(Kabakov, 1998; Alekseev et al., 2012). Similar close functional
interaction between the α2 Na,K-ATPase isozyme and the KATP
channels was shown in vascular smooth muscle cells (Glavind-
Kristensen et al., 2004; Matchkov et al., 2007).
In skeletal muscle cells, the α1 and α2 Na,K-ATPase isozymes
also have distinct distributions and membrane localization. The
α1 isozyme comprises up to 40% of total Na,K-ATPase and is
expressed only on the outer plasma membrane. The α2 isozyme
comprises 60–80% of total Na,K-ATPase content (Orlowski and
Lingrel, 1988; He et al., 2001) and the majority of the α2 isozyme
is expressed in the interior transverse tubule membranes, with
smaller pools localized to the end-plate membrane and surface
caveolae (Williams et al., 2001; Cougnon et al., 2002; Heiny et al.,
2010; Kristensen and Juel, 2010). Diffusion alone is not sufficient
Frontiers in Physiology | www.frontiersin.org 3 May 2016 | Volume 7 | Article 179
Matchkov and Krivoi Functional Na,K-ATPase Interactions
to remove the excitation-related K+ load in the T-tubules, the
concentration of which, reaches tens of millimolar (Sejersted and
Sjogaard, 2000; Clausen, 2013). The existence of two α isozymes
of the Na,K-ATPase with distinct locations and K+ affinities was
proposed (DiFranco et al., 2015). The α1 isozyme with relatively
high K+ affinity mediates most of the basal Na+ and K+ ion
transport and plays amajor role in setting resting transmembrane
ion gradients and resting membrane potential. Located in T-
tubules α2 isozyme with apparently low K+ affinity operates
substantially below its maximum capacity in the resting muscles,
but its activity can rapidly increase during membrane excitation
and K+ accumulation. This helps to maintain muscle excitability,
contraction, and oppose fatigue.
The Na,K-ATPase containing membrane microdomains were
shown to be associated to the “junctional” SR and include
the NCX as one of the key functional players (Moore
et al., 1993; Juhaszova and Blaustein, 1997; Golovina et al.,
2003; Lynch et al., 2008). These microdomains were shown
in a variety of cell types including neurons, glia, and
myocytes. Other membrane proteins were also shown to co-
localize in these microdomains, e.g., diverse plasma membrane
Ca2+ channels, sarco/endoplasmic reticulum Ca2+-ATPase
(SERCA), sarcoplasmic reticulum IP3, and ryanodine receptors
(Blaustein and Golovina, 2001; Blaustein, 2013). In these
specialized microdomains, called “PLasmERosome,” the Na,K-
ATPase and its molecular environment function cooperatively to
regulate locally the intracellular Ca2+ signaling (Blaustein and
Golovina, 2001; Blaustein, 2013). The plasma membrane and
SR components appear to be linked through the cytoskeletal
spectrin network and adaptor protein, ankyrin 2 (Lencesova
et al., 2004). These microdomains specifically contained ouabain-
sensitive α2 or α3 Na,K-ATPase isozymes. The N-terminal
sequence targets and tethers the α2 Na,K-ATPase isozyme to its
specific localization in the plasma membrane (Song et al., 2006).
Restriction of Na+ and Ca2+ diffusion enables the appearance
of concentration gradients between these restricted spaces and
the bulk cytosol. Interestingly, the α2 Na,K-ATPase isozyme have
much lower affinities for Na+ than the α1 isozyme (Zahler et al.,
1997). This suggests that intracellular Na+ will rise more in
the restricted spaces controlled by the α2 Na,K-ATPase isozyme
than the global intracellular Na+ which is under α1 isozyme
control. Thus, these α2-isozyme-associated-microdomains are
well-organized to control the local Na+ electrochemical gradient
which can influence Ca2+ homeostasis via the co-localized NCX
isoform 1 (Golovina et al., 2003; Lynch et al., 2008). This links
cellular Ca2+ concentration to Na+ concentration; a spatially
restricted rise in Na+ will lead to a localized elevation of
intracellular Ca2+. Such interactions in ion metabolism do not
only control local Ca2+ but also affect global intracellular Ca2+
via modulation of the SR load. This interaction generally explains
the well-known potentiating effect of ouabain on vascular
contraction (Miriel et al., 1999; Iwamoto et al., 2004; Zhang et al.,
2005, 2010; Blaustein and Wier, 2007).
Alterations in the Na,K-ATPase activity will change the
cellular Ca2+ homeostasis and enhance loading of intracellular
Ca2+ stores (Golovina et al., 2003). This has normally been
considered a result of the elevation in the intracellular Na+
concentration slowing the clearance of Ca2+ by NCX and,
therefore, allowing extra Ca2+ pumped into the stores (see
above). The reduction of α2 isozyme activity (either by knocking
it down or by pharmacological inhibition) should therefore, be
associated with elevated contractility of vascular smooth muscle
cells, although this is not always the case. It has been previously
reported that, in contrast to the effect of ouabain, a transient
siRNA-induced downregulation of the α2 Na,K-ATPase isozyme
suppresses contractile responses of rat mesenteric small arteries
(Matchkov et al., 2012). Although ouabain increased sensitivity
to the contractile stimuli in control arteries, it had no effect on the
α2-isozyme-downregulated arteries. Surprisingly, the reduced
expression of α2 isozyme was associated with higher intracellular
Ca2+ concentration but suppressed contractile response of
the arterial wall (Matchkov et al., 2012). This suggests that
downregulation of the α2 Na,K-ATPase isozyme led to reduction
in Ca2+-sensitivity of vascular smooth muscle cell contractile
machinery.
These surprising findings might seem to be contrasting to
other reports where small arteries from α2-isozyme-knockout
mice showed an increased myogenic tone (Iwamoto et al.,
2004; Shelly et al., 2004; Dostanic et al., 2005; Zhang et al.,
2005). However, the α2-isozyme-downregulated arteries also
had increased myogenic contraction possibly due to elevated
basal intracellular Ca2+ which might be a consequence of
coordinated reduction in the NCX expression (Matchkov et al.,
2012). Stimulation with agonists was, however, less effective in
the α2-isozyme-downregulated arteries where both sensitization
to Ca2+ and Ca2+ release through the IP3 receptors were
suppressed. The reason for this compromised agonist-induced
Ca2+ sensitivity in the arteries with reduced α2 Na,K-ATPase
isozyme expression is not known but it suggests a more complex
mechanism for the control of smooth muscle contractility by
the Na,K-ATPase than the modulation of intracellular Ca2+
concentration via membrane potential (Mulvany et al., 1984;
Aalkjaer and Mulvany, 1985) and ion homeostasis (Golovina
et al., 2003; Lynch et al., 2008).
A direct interaction of the αNa,K-ATPase subunit N-terminus
with IP3 receptor has been established suggesting that ouabain-
induced conformational changes in the α subunit can directly
liberate Ca2+ from intracellular depot (Aizman et al., 2001;
Zhang et al., 2006; Tian and Xie, 2008). Importantly, ouabain-
evoked Ca2+ signaling can not only affect the contractility
of cardiac and smooth muscles but also regulates via the
Ca2+-sensitive transcription factors protein expression, cell
proliferation, and differentiation (Aizman et al., 2001; Fontana
et al., 2013).
In membrane microdomains the Na,K-ATPase is shown to
be organized together with interacting proteins in signalosome
(Aydemir-Koksoy et al., 2001; Wang et al., 2004; Efendiev et al.,
2005; Tian et al., 2006) restricted to caveolae (Wang et al.,
2004; Liu and Askari, 2006; Schoner and Scheiner-Bobis, 2007;
Tian and Xie, 2008; Liu et al., 2011; Morrill et al., 2012).
Caveolin is a protein essential for caveolae formation and
direct Na,K-ATPase/caveolin interaction was previously shown
(Wang et al., 2004; Cai et al., 2008; Heiny et al., 2010; Morrill
et al., 2012). Cholesterol-richmembranemicrodomains, i.e., lipid
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rafts and caveolae, are nanoscale assemblies of sphingolipid,
cholesterol, and proteins that form platforms for subcellular
signaling and trafficking (Razani et al., 2002; Lingwood and
Simons, 2010; Harvey and Calaghan, 2012; Sebastiao et al.,
2013). The formation of cholesterol rich lipid microdomains is
important for Na,K-ATPase targeting and regulation and the
reciprocal interactions between the Na,K-ATPase and cholesterol
were proposed (Cornelius, 2008; Chen et al., 2011; Kapri-Pardes
et al., 2011; Haviv et al., 2013; Cornelius et al., 2015).
THE Na,K-ATPase/SRC SIGNALING
PATHWAY
In the functional signalosome the Na,K-ATPase has been
suggested to interact and regulate protein kinases as well as
function as scaffold protein for receptors and effectors (Li and
Xie, 2009). The experimental findings during the last decade
suggest that the Na,K-ATPase can function as an important
signal transducer (Aizman and Aperia, 2003; Li et al., 2009; Liu
and Xie, 2010). Indeed, two functionally separate pools of the
Na,K-ATPase have been suggested to be engaged in the “classic”
ion transport and cellular activities other than ion pumping (Xie
et al., 2015).
The unconventional non-pumping Na,K-ATPase resides in
restricted membrane microdomains, where it directly interacts
with protein kinases, ion channels, and transporters (Xie,
2003; Xie and Cai, 2003). Thus, it has been shown that the
central loop of Na,K-ATPase interacts with phospholipase C-γ
(PLCγ) and the N-terminus binds to IP3 receptors (Yuan
et al., 2005). This signalosome comprises also several anchoring
proteins, Src kinase and has been shown to be an important
modulator of intracellular Ca2+ signal (Haas et al., 2000; Liu
et al., 2000). Ouabain can act through this signalosome in
two synergistic manners (Yuan et al., 2005). First, it can force
PLCγ and IP3 receptors into close proximity and facilitate the
signal transmission. Second, an activation of the Na,K-ATPase-
associated Src could lead to tyrosine phosphorylation of both
PLCγ and the IP3 receptors that will sensitize the receptor
to IP3 produced by PLCγ. In this term, the Na,K-ATPase-Src
interaction is important not only for ouabain signaling but
also for many other agonist-induced intracellular responses that
involve IP3 signaling and tyrosine phosphorylation in general.
Binding of ouabain to the Na,K-ATPase releases Src kinase that
can affect intracellular Ca2+ as well as modulate other signaling
pathways including gene expression (Xie and Cai, 2003).
Although there is some controversy regarding an interaction
between the Na,K-ATPase and Src kinase, an activation of
Src kinase by phosphorylation is a well-established response
to submicromolar concentrations of ouabain. Several studies
suggest that the Na,K-ATPase-associated Src kinase specifically
activated by ouabain (Haas et al., 2000; Liang et al., 2006;
Tian et al., 2006; Li et al., 2009; Lai et al., 2013; Ye et al.,
2013; Banerjee et al., 2015). This signaling microdomain model
disagreed with other studies suggesting that ouabain-induced
Src kinase activation is a result of the ATP-sparing effect of the
Na,K-ATPase inhibitor on these two enzymes competing for ATP
(Weigand et al., 2012; Gable et al., 2014). However, some skeletal
muscle studies showed that submicromolar and micromolar
concentrations of ouabain do not affect the global intracellular
ATP/ADP ratio while significant phosphorylation of Src kinase
and its activation were observed (Kotova et al., 2006a,b).
Nevertheless, these studies addressed the global ATP/ADP ratio,
and there is a possibility for spatially restricted changes in the
concentrations. Accordingly, it has been shown that the Na,K-
ATPase-dependent Src kinase activity is maintained in cells
expressing a non-pumping mutant of rat α1 isoform (Liang et al.,
2006). The involvement of Na,K-ATPase in signaling cascade
does not exclude a role for its ion pumping function in ouabain-
induced effects. Moreover, since intracellular Na+ ions regulate
the conformation of the Na,K-ATPase (e.g., the E1 state), it is
possible that changes in intracellular Na+ concentration could
also regulate the formation of the Na,K-ATPase/Src complex,
and thus cellular Src activity (Li et al., 2009). This Na,K-ATPase-
dependent Src kinase signaling is hypothesized to modulate
arterial contraction and blood pressure as discussed below.
Na,K-ATPase AND HYPERTENSION
The correlation between circulating ouabain and blood pressure
was suggested almost 35 years ago (Hamlyn et al., 1982). Almost
50% of patients with uncomplicated essential hypertension have
been reported to have elevated endogenous ouabain (Rossi
et al., 1995). In accordance with hemodynamic background
of hypertension characterized by an increase in peripheral
resistance and unchanged cardiac output, plasma ouabain level
correlates positively with elevated peripheral resistance and left
ventricular hypertrophy, but not with cardiac output (Manunta
et al., 1999; Pierdomenico et al., 2001). Also other endogenous
CTS correlate with blood pressure, e.g., urinary marinobufagenin
level increases with elevated blood pressure and aortic stiffness in
patients (Jablonski et al., 2013).
These human studies received further strong experimental
support from several animal models of ouabain-dependent
hypertension. Chronic administration of ouabain, leading to
an increase of its plasma concentration to the level observed
in essential hypertension, produced hypertension in rats (Yuan
et al., 1993; Manunta et al., 2000; Pulgar et al., 2013). This
ouabain-induced hypertension was associated with elevated
peripheral vascular resistance that is a result of inward arterial
structural remodeling (Briones et al., 2006) and increased
contractility of the resistance arteries (Pulgar et al., 2013).
Endogenous ouabain-like inhibitor of the Na,K-ATPase was
also implicated in pulmonary hypertension (Janssens et al.,
1993). Plasma ouabain level is elevated in several other rodent
models of hypertension, including DOCA-salt, reduced renal
mass, Milan hypertensive rats, Dahl S rats on high-salt diet, and
adrenocorticotropic hormone induced hypertension (for review
see: Blaustein et al., 2012).
Inhibition of endogenous ouabain action by systemic
administration of ouabain antagonist rostafuroxin or digibind
(an antibody to endogenous ouabain) lowers blood pressure and
even prevents hypertension in the high-ouabain hypertension
models (Dostanic-Larson et al., 2005; Manunta et al., 2006).
Finally, knock-in of ouabain-resistant mutation of the α2
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Na,K-ATPase isozyme prevents ouabain-induced hypertension
(Dostanic et al., 2005; Dostanic-Larson et al., 2005; Lorenz
et al., 2008). This indicates the importance of the α2 isozyme
in pathogenesis of hypertension. The importance of the α1
Na,K-ATPase isozyme was, however, also suggested. Thus,
blood pressure was shown to correlate with the expression
of either α1 or α2 isozyme (Pritchard et al., 2007). However,
these two isozymes have coordinated expression profiles, where
overexpression of one isozyme increased the expression of
another. This makes it therefore difficult to distinguish their
specific roles, although it had been concluded that the α2 Na,K-
ATPase isozyme seems to play more significant role (Pritchard
et al., 2007).
Presently, there is no generally acceptedmolecularmechanism
which could explain how the inhibition of Na,K-ATPase leads
to an elevation of blood pressure. The situation is further
complicated by the fact that not all CTS have a similar effect
on blood pressure. Thus, in contrast to ouabain, digoxin does
not raise blood pressure and has even antihypertensive action in
ouabain-dependent hypertension models (Manunta et al., 2000;
Zulian et al., 2013). Nevertheless, all known “classic” CTS inhibit
the Na,K-ATPase pumping activity and exert vasotonic effects in
vitro; however, digoxin-like steroids can antagonize the vasotonic
effects of ouabain-like steroids, and vice versa (Song et al., 2014).
This phenomenon of ouabain-digoxin antagonism is not unique
for blood vessels and is also characteristic for glutamate-induced
Ca2+-transients in primary cultured hippocampal neurons (Song
et al., 2014).
Ouabain-digoxin antagonism might be a result of functional
selectivity or biased signaling of the Na,K-ATPase as it is known
for some G-protein-coupled receptors (Kenakin, 2011; Kenakin
and Christopoulos, 2013). Thus, the possibility for different
conformational changes of the Na,K-ATPase upon a binding of
different CTS has been hypothesized to be the reason for different
functional effects in spite of their uniform inhibitory action.
However, recent crystal structure analyses of the high-affinity
Na,K-ATPase-ouabain and -digoxin complexes do not support
this possibility, although they do not exclude it (Laursen et al.,
2013, 2015).
It has been suggested that the Na,K-ATPase functions as a
tetraprotomer (Hah et al., 1985) where single CTS blocks all
pumping activity but digoxin-like steroids are able to reactivate
the ouabain-inhibited tetraprotomers via de-oligomerization
(Song et al., 2014). This antagonism is shown for resistance
arteries in vitro. However, ouabain-like steroids elevate blood
pressure while digoxin-like steroids do not and even antagonize
the effect of ouabain (Manunta et al., 2000; Zulian et al., 2013).
Thus, only one direction of ouabain-digoxin antagonism can be
seen in vivo in contrast to in vitro experiments (Song et al., 2014).
Low constitutive level of endogenous ouabain was implicated in
this inconsistency.
MODULATION OF ARTERIAL
CONTRACTILITY BY THE Na,K-ATPase
In vitro studies suggest that many of the functional and
structural alterations in arteries from hypertensive animals could
be consequences of elevated plasma ouabain (Blaustein et al.,
2012). The Na,K-ATPase has a significant role in regulation of
vascular tone and contractility, and therefore has been proposed
to modulate peripheral vascular resistance and blood pressure
(Blaustein and Wier, 2007). Two α-isozymes of the Na,K-
ATPase are expressed in vascular smooth muscles, where the
α1 Na,K-ATPase isozyme is homogeneously distributed over the
cell membrane while the α2 isozyme has a spatially restricted
distribution (Lee et al., 2006; Matchkov, 2010).
Activation of the Na,K-ATPase results in membrane
hyperpolarization and vascular relaxation while its inhibition
causes membrane depolarization and vascular contraction.
Inhibition of the Na,K-ATPase by ouabain in a broad
concentration range between 0.01 µM and 1mM had no
effect on resting vascular tone while it significantly potentiated
the agonist-induced contraction (Aalkjaer and Mulvany,
1985). Accordingly, ouabain produced acute and transient
(within 10 min) concentration-dependent depolarization of
smooth muscles in both resting and agonist-stimulated arteries
(Nilsson and Mulvany, 1981; Mulvany et al., 1982; Aalkjaer
and Mulvany, 1985). At the same time, a prolonged exposure
to micromolar concentrations of ouabain suppressed arterial
contractility (Nilsson et al., 2001). The reason for these short-
term potentiating and long-term depressive effects of arterial
contraction is unknown. It has been suggested that under
physiological conditions ouabain-induced depolarization and
the following voltage-dependent Ca2+ influx play an important
role in the potentiation of arterial contraction, although the role
of intracellular Na+ for the NCX modulation should not be
underestimated (Mulvany et al., 1984; Aalkjaer and Mulvany,
1985). Simultaneous analyses of contraction and intracellular
Ca2+ concentration changes demonstrated also that the long-
term depressive effect of ouabain on arterial contraction was due
to desensitization of smooth muscle contractile machinery to
Ca2+ ions (Nilsson et al., 2001).
The discussed above hypothesis about Na,K-ATPase-
dependent Src kinase signaling is mostly based on the studies
with epithelial cells (Aizman and Aperia, 2003; Yuan et al., 2005;
Li et al., 2009; Liu and Xie, 2010; Lai et al., 2013). However,
previous study showed opposite effects of two Na,K-ATPase
inhibitors, ouabain and digoxin, on blood pressure (Manunta
et al., 2000). It has been suggested that although both of
inhibitors block pumping activity of the Na,K-ATPase, only
ouabain elevates intracellular Ca2+ through an activation of
the Src kinase (Zulian et al., 2013). Digoxin, which is unable to
activate Src kinase, fails to potentiate smooth muscle contraction.
Thus, this strongly suggests the importance of the Na,K-ATPase-
Src signaling pathway in regulation of arterial tone and suggests
that hypertensive action of endogenous ouabain-like steroids is
mediated via Src kinase signaling. This is in accordance with
the functional study on isolated arterial segments showing the
importance of Src signaling for vascular tone control (Toma
et al., 1995).
Digoxin-related synthetic steroid, rostafuroxin (Quadri et al.,
1997) does not affect pumping activity of the Na,K-ATPase
(Ferrari et al., 1998) and has itself no effect on the arterial
tone (Zhang et al., 2005). It antagonizes, however, the vasotonic
action of ouabain-like CTS (Song et al., 2014) and hypertension
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associated with an elevation of endogenous ouabain level
(Ferrari, 2010). This antihypertensive effect of rostafuroxin has
been associated with suppression of ouabain-induced Src-kinase-
dependent signaling pathway (Wenceslau and Rossoni, 2014).
The importance of the α1 Na,K-ATPase isozyme for initiation
of the Src kinase signaling has been shown (Xie et al., 2015),
although whether this is also the case for vascular smooth
muscle cells remains to be identified. The specific Src-kinase-
dependent pathways upon ouabain binding by the Na,K-ATPase
remain to be elucidated but this signaling was shown in
several studies with smooth muscle cells in culture (Haas
et al., 2000, 2002; Liu et al., 2004). Activation of Src kinase
triggers Src-dependent phosphorylation of epidermal growth
factor receptor and an activation of Ras/MAPK (mitogen-
activated protein kinase) cascade (Haas et al., 2000, 2002)
as well as numerous other signaling pathways important for
vascular smooth muscle function and phenotype (for review:
MacKay and Knock, 2015). Src kinases in smooth muscles
were shown to be involved in reactive oxygen species signaling
(Akhand et al., 1999; Giannoni et al., 2005; Knock and Ward,
2011), G-protein-coupled receptor stimulations (Luttrell and
Luttrell, 2004), tyrosine phosphorylation of transient receptor
potential channels (Kawasaki et al., 2006), voltage-gated Ca2+
channels (Wijetunge et al., 2000; Gui et al., 2010) and K+
channels (Alioua et al., 2002; Sung et al., 2013), modulation
of Rho pathways (Guilluy et al., 2010; Gadepalli et al., 2012)
and myosin phosphatase activity (Velasco et al., 2002). These
signaling pathways will affect intracellular Ca2+ concentration
and sensitization of contractile machinery to Ca2+, modulate
proliferation and apoptosis suggesting their role in vascular
repair and remodeling.
OTHER Na,K-ATPase DEPENDENT
SIGNALING PATHWAYS IN THE VASCULAR
WALL
In addition to the Src kinase signaling, the importance of which
still needs to be validated for the vasculature, the Na,K-ATPase
has been shown to interact in the arterial wall with several other
signaling pathways. Thus, the Na,K-ATPase associates with salt-
inducible kinase 1 (SIK1), a sucrose-non-fermenting-like isoform
of the 5′-adenosine monophosphate-activated protein kinase
(AMPK) family (Sjostrom et al., 2007). A Ca2+/calmodulin-
dependent activation of SIK1 results in the de-phosphorylation of
the α subunit Na,K-ATPase and an increase its catalytic activity.
This pathway is shown to be activated by high salt intake in
both kidneys (Sjostrom et al., 2007) and human vascular smooth
muscle cells (Popov et al., 2011). Interestingly, a single nucleotide
polymorphism of SIK1 has associated with low blood pressure
and decreased left ventricle mass suggesting the importance of
this signaling for blood pressure control (Popov et al., 2011).
Glutathionylation of β1 subunit of the Na,K-ATPase is
an important pathway to modulate Na,K-ATPase activity by
physiological and pathophysiological stimuli. Thus, angiotensin
II has previously been shown to inhibit the Na,K-ATPase in
vascular smooth muscle cells via NADPH oxidase-dependent
glutathionylation of β1 subunit suggesting the involvement of
this pathway in elevation of arterial tone and angiotensin-
induced hypertension (Liu et al., 2013). Importantly, this action
was antagonized by FXYD proteins showing their important
vascular protective role under oxidative stress (Liu et al., 2013).
The glutathionylation pathway has also been shown to play
an important role in agonist-induced inhibition of the Na,K-
ATPase activity in smooth muscle cells (Dey et al., 2013). An
antagonistic action of FXYD1 protein, phospholemman (PLM)
was associated with de-glutathionylation of the Na,K-ATPase and
has been suggested to be modulated via protein kinase C (PKC)
phosphorylation (Dey et al., 2012). This PKC mediated signaling
stimulates the Na,K-ATPase turnover without affecting affinity
for Na+. In pulmonary artery wall, PKC was also implemented
in Na,K-ATPase inhibition by HETE-20, a cytochrome P-450
metabolite of arachidonic acid (Singh et al., 2012). This action
explains a moderate potentiation of vascular tone by arachidonic
acid. Finally, PKC is involved in modulation of the α2 Na,K-
ATPase isozyme upon adrenoceptor stimulation while the α1
Na,K-ATPase isozyme is regulated by β-adrenoceptor-dependent
protein kinase A signaling (Gao et al., 1999).
CONTROL OF INTERCELLULAR
COUPLING BY THE Na,K-ATPase
Na,K-ATPase is involved in modulation of vascular tone
by endothelium (Edwards et al., 1998; Dora and Garland,
2001; Wenceslau and Rossoni, 2014; Hangaard et al., 2015).
Hyperpolarization of endothelial cells by chemical or mechanical
excitation facilitates Ca2+ influx which, in this way, enhances
the production of endothelium-derived relaxing factors.
Besides nitric oxide (NO) and prostanoids the endothelium-
dependent relaxation is mediated by an endothelium-dependent
hyperpolarizing factor (EDHF) (Sandow, 2004; Edwards et al.,
2010). Vasodilator effects of EDHF are strongly associated with
the subjacent smooth muscle cell hyperpolarization but its
nature remains controversial. It is, however, well-established that
EDHF is critically dependent on endothelial Ca2+-activated K+
channels, KCa2.3 and KCa3.1 (Coleman et al., 2004; Sandow,
2004). Strong experimental data indicates also the significance of
myoendothelial gap junctions (MEGJs) and the Na,K-ATPase in
EDHF (Edwards et al., 1998; de Wit et al., 2006; Dora et al., 2008;
Hangaard et al., 2015).
The heterogeneous nature of signals could be the reason for
different EDHF properties depending on the type of vascular
bed and experimental conditions. Thus, in rat mesenteric
arteries EDHF can only in part be explained by MEGJs
signaling (Edwards et al., 1998). It has been suggested that
under these conditions K+ eﬄux through the Ca2+-activated
intermittent conductance K+ channels (e.g., KCa3.1) increases
near myoendothelial projections local K+ concentration (K+
“cloud”) which, in turn, activates on the Na,K-ATPase in smooth
muscle cell membrane (and inward-rectifying K+ channels)
providing hyperpolarization of the subjacent smooth muscle
cells. Which catalytic subunit of the Na,K-ATPase is important
for this signal is under debate but pharmacological profile (Dora
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and Garland, 2001; Dora et al., 2008) and a high extracellular K+
saturation (McCarron and Halpern, 1990; Blanco and Mercer,
1998) suggested a major importance of the α2 Na,K-ATPase
isozyme (Longden and Nelson, 2015). Moreover, it has been
suggested a specific localization of the α2 Na,K-ATPase isozyme
in myoendothelial projections in a close proximity with Ca2+-
sensing receptor (CaSR) and KCa3.1 (Dora et al., 2008).
It has been suggested that EDHF signals differentiate between
MEGJs and K+ “cloud” by CaSR action on the KCa3.1 channels
via protein kinase A pathway (Dora et al., 2008; Hangaard
et al., 2015). This differentiation is overlapping since the
Na,K-ATPase activity has been shown to modulate intercellular
coupling, including MEGJs (Martin et al., 2003; Matchkov
et al., 2007, 2012). It has been shown that a spatially restricted
microdomain of the Na,K-ATPase and the NCX (Matchkov et al.,
2007) modulates intercellular communications between smooth
muscle cells via controlling local intracellular Ca2+ homeostasis.
Moreover, a physical interaction in the membrane microdomain
between the α2 Na,K-ATPase isozyme, NCX and gap junction
protein, connexin43 was shown (Matchkov, 2010). The role of α2
Na,K-ATPase isozyme was further validated by siRNA-induced
downregulation and importance of this signaling for MEGJs was
shown (Matchkov et al., 2012). In accordance with the suggested
role of Na,K-ATPase for intercellular coupling pharmacological
inhibition with ouabain and downregulation of the α2 Na,K-
ATPase isozyme suppressed intercellular coupling and inhibited
EDHF response in arteries (Matchkov et al., 2007, 2012).
Signaling pathway between the Na,K-ATPase and gap
junctions is unclear. We suggested previously a Ca2+-
dependence of uncoupling action of ouabain (Matchkov
et al., 2007); however, the involvement of other signaling
molecules cannot be excluded. Thus, intracellular Ca2+ ions
can modulate gap junction directly (Enkvist and McCarthy,
1994; Schirrmacher et al., 1996; Thimm et al., 2005) and via
Ca2+-dependent protein kinase pathways (Chuderland and
Seger, 2008; Chuderland et al., 2008). Three to four types of
connexins form gap junctions in the vascular wall (Gustafsson
et al., 2003; Matchkov et al., 2006) but connexin43 is a suitable
candidate for the regulation via Na,K-ATPase signaling.
Connexin43 expressed in cultured smooth muscle cells, A7r5
(Moore et al., 1991) where this signaling is also shown and is
one of the most heavily regulated gap junction proteins. It has
been shown to be regulated by intracellular Ca2+ concentration
and a broad range of intracellular signaling pathways (Lampe
and Lau, 2004). Other connexin isoforms also cannot be
excluded.
BI-MODAL VASCULAR EFFECTS OF
OUABAIN
Importantly, vascular effects of ouabain can be subdivided to
acute and chronic responses. In contrast to acute responses,
chronic manipulations with the Na,K-ATPase have been shown
to affect the expression of membrane proteins involved in Ca2+
transport, e.g., the NCX and C-type transmembrane receptor
potential protein-6 (TRPC6) (Pulina et al., 2010; Matchkov et al.,
2012; Chen et al., 2015). These expressional effects were suggested
to be mediated by the α2 Na,K-ATPase isozyme via an initiation
of protein kinase signaling cascade, including the Src kinase
pathway. Accordingly, pharmacological inhibition of tyrosine
phosphorylation prevented the expressional effects of chronic
ouabain treatment (Zulian et al., 2013) but did not affect vascular
responses to acute ouabain (Song et al., 2014). Downstream
signalings from Src kinase activation, e.g., extracellular signal-
regulated kinases 1/2 (Erk1/2) and p38, have been shown to
modulate protein expression and affect cellular phenotype (Haas
et al., 2000, 2002; Aizman and Aperia, 2003; Nguyen et al., 2007;
Li et al., 2009; Wang et al., 2014, 2015). The involvement of
other signaling pathways in the modulation of cellular phenotype
cannot be excluded (Liu et al., 2007; Wu et al., 2013).
The structural remodeling of resistance arteries is an essential
characteristic of hypertension (Heagerty et al., 1993; Mulvany,
1993, 2002). The functional link between arterial wall thickening
and/or lumen narrowing and elevated level of endogenous
ouabain-like steroids is unresolved. Ouabain has been shown
to promote cell growth, proliferation and migration (Atkinson
et al., 1983; Aydemir-Koksoy et al., 2001; Abramowitz et al.,
2003; Allen et al., 2003; Liu et al., 2004, 2014; Schoner and
Scheiner-Bobis, 2007). This action of ouabain has been suggested
to be mediated through both changes in ion homeostasis
and intracellular signaling pathways (Blaustein et al., 2012).
Obviously, an identification of these pathways involved in
structural remodeling is one of the central questions in future
strategies of hypertension treatment; but, unfortunately, this was
not in the scope of the majority of previous studies.
Na,K-ATPase AND SKELETAL MUSCLE
MOTOR ACTIVITY
The Na,K-ATPase is obligatory for excitability, electrogenesis,
and contractility of skeletal muscles (Sejersted and Sjogaard,
2000; Clausen, 2008, 2013) which express the α1 and α2 Na,K-
ATPase isoforms (Orlowski and Lingrel, 1988). The α2 Na,K-
ATPase isozyme specifically enables workingmuscles to maintain
contraction and resist fatigue (Radzyukevich et al., 2004, 2013;
Heiny et al., 2010; DiFranco et al., 2015; Kravtsova et al., 2016).
Skeletal muscle activity strongly upregulates the content of Na,K-
ATPase although the α1 and α2 isozymes are regulated differently
(Yuan et al., 2007; Clausen, 2008; Kristensen et al., 2008; Murphy
et al., 2008; Juel, 2009; Nordsborg et al., 2009). Accordingly,
physical inactivity of skeletal muscle induced by functional
unloading (disuse) reduces the content of Na,K-ATPase (Clausen,
2008). However, the isoform-specificity of these changes was not
studied in details.
Mechanical unloading of skeletal muscle under bed rest, joint
immobilization, spinal cord injury, or other forms of muscle
disuse leads to loss of muscle mass and functional decline
(Baldwin et al., 2013; Bodine, 2013; Brooks and Myburgh, 2014).
Weightless conditions during space flight and microgravity are
also known to induce similar adaptations in skeletal muscles with
the largest effect seen in postural muscles such as soleus (Fitts
et al., 2013). Importantly, molecular and cellular mechanisms of
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disuse-induced atrophy are not completely understood (Baldwin
et al., 2013; Bodine, 2013; Brooks and Myburgh, 2014).
The hindlimb suspension (HS) of rodents is a well-validated
model for skeletal muscle disuse providing an insight into
underlying mechanisms of disuse-induced atrophy (Thomason
and Booth, 1990; Morey-Holton et al., 2005; Shenkman and
Nemirovskaya, 2008; Giger et al., 2009; Baldwin et al., 2013).
HS leads to progressive and marked atrophy of the postural
skeletal muscles which becomes evident already after 3–7
days and is associated with dramatic remodeling (Shenkman
and Nemirovskaya, 2008; Baldwin et al., 2013; Pierno et al.,
2013; Ogneva et al., 2014) that include a decrease of resting
membrane potential (Desaphy et al., 2001; Pierno et al., 2002;
Krivoi et al., 2008; Tyapkina et al., 2009). This membrane
depolarization was shown to be a result of decreased electrogenic
activity of the α2 Na,K-ATPase isozyme (Krivoi et al., 2008).
Moreover, it was recently shown that short-term muscle disuse
(6–72 h of HS) transiently and isoform-specifically regulates the
electrogenic activity, protein, and mRNA content of α2 Na,K-
ATPase isozyme in rat soleus muscle (Kravtsova et al., 2015a,
2016) (Figures 1A,B). Importantly, electrogenic activity of the
α2 Na,K-ATPase isozyme was altered by a decrease in enzyme
activity rather than as a consequence of altered mRNA and
protein contents or localization in the sarcolemma. The loss of α2
Na,K-ATPase electrogenic activity on extrajunctionalmembranes
containing a majority of α2 pump cannot be compensated by
increase of protein and mRNA contents observed after 12 h
of HS. In contrast, a small subset of junctional α2 Na,K-
ATPase demonstrated recovery (Figure 1C) suggesting that
distinct pools of the α2 isozyme are differently regulated during
HS. Importantly, acute low-intensity muscle workload restores
function of both pools of the α2 Na,K-ATPase (Kravtsova et al.,
2016).
These disuse-induced alterations in α2 Na,K-ATPase
isozyme function and expression may involve PLM-dependent
regulatory mechanism (Kravtsova et al., 2016). Muscle-specific
auxiliary FXYD1 subunit, PLM is one of the most abundant
phosphoproteins in skeletal muscles. PLM acts as a tissue-specific
regulator of the Na,K-ATPase which suppresses enzymatic
activity mostly by reducing Na+ affinity. Phosphorylation
of PLM removes this inhibition and thereby increases the
Na,K-ATPase pumping activity. Thus, protein kinases A (PKA)
and C alter the PLM substrate affinity or turnover in cell-
and Na,K-ATPase isoform-specific manner (Geering, 2008;
Bossuyt et al., 2009; Pavlovic et al., 2013). In muscular tissues
PLM associates with both α1 and α2 Na,K-ATPase isozymes
(Crambert et al., 2002; Reis et al., 2005; Bossuyt et al., 2009; Heiny
et al., 2010; Chibalin et al., 2012) where at least 30% of them are
associated with the PLM (Rasmussen et al., 2008). Although the
exercise-induced regulation of PLM was previously shown (Juel,
2009), the mechanism behind it remains to be elucidated. It was
shown that acute HS increased PLM phosphorylation at Ser63
and Ser68 (Kravtsova et al., 2016). This is expected to stimulate
the Na,K-ATPase and might be an earlier adaptive response
directed to counteract the loss of enzyme activity. At the same
time an increased abundance and association of PLM with the
α2 Na,K-ATPase were shown to provide an opposite inhibitory
FIGURE 1 | Short-term hindlimb suspension specifically and transiently
alters the α2 Na,K-ATPase protein content (A), mRNA content (B), and
electrogenic activity (C) in rat soleus muscle. (A,B) Relative α1 (white
bars) and α2 (gray bars) Na,K-ATPase protein and mRNA contents in the
homogenates from muscles of control rats and after 6–72 h of hindlimb
suspension (data normalized to the average level of expression under control
conditions). (C) The electrogenic transport activity of the α2 Na,K-ATPase
isozyme measured in the extrajunctional and junctional membrane regions of
muscle fibers. **p < 0.01 compared to corresponding control. Modified from
Kravtsova et al. (2015a, 2016).
effect and the net pump inhibition was achieved (Kravtsova et al.,
2016).
A unique role of the α2 Na,K-ATPase isozyme in the
adaptations to skeletal muscle disuse is supported by the
studies in humans. Thus, chronic disuse resulting from spinal
cord injury (Boon et al., 2012) or knee injury (Perry et al.,
2015) significantly decreased the α2 Na,K-ATPase content in
human skeletal muscles. These findings raise an interesting
question whether the α2 Na,K-ATPase content or activity is
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regulated during other forms of disuse, e.g., sleep or treatment
with muscle relaxants and anesthetics. It has been shown that
electromyography (EMG) signal from soleus muscle disappears
immediately after the onset of HS and remains dramatically
low for several days (Ohira et al., 2002; De-Doncker et al.,
2005). In contrast, different forms of periodic limb movement
occurring during sleep (De Weerd et al., 2004) associate
with brief EMG bursts and soleus muscle contractions (Eken,
1998). Accordingly, it was recently shown that a minimal low-
intensity workload is able to restore electrogenic activity of
the α2 Na,K-ATPase isozyme in soleus muscle of hindlimb-
suspended rats (Kravtsova et al., 2016). These findings are in
agreement with observation that limited physical activity is
able to maintain abundance of the Na,K-ATPase in skeletal
muscles of patients with partial spinal injury (Boon et al., 2012).
Another potential experimental model to study the regulation of
the Na,K-ATPase by muscle use could be hibernating animals,
which overcome muscle atrophy despite prolonged disuse in
dormancy.
Taken together, these results suggest that alterations specific
for the α2 Na,K-ATPase precede disuse-induced skeletal muscle
atrophy and indicate that different pools of this isozyme are
regulated differently. Importantly, acute HS did not alter activity
and content of the α1 Na,K-ATPase isozyme (Figures 1A,B).
These findings are consistent with generally accepted hypothesis
that ubiquitous α1 isozyme in skeletal muscle, as well as in
other tissues, plays the main “house-keeping” role while the
α2 Na,K-ATPase isozyme involved preferably in the regulation
of cellular functions (Lingrel, 2010; Matchkov, 2010; Krivoi,
2012; Shattock et al., 2015). Specific regulation of the α2 Na,K-
ATPase might be determined by its functional and molecular
environment (Blaustein and Golovina, 2001; Lencesova et al.,
2004; Song et al., 2006; Blaustein, 2013; DiFranco et al., 2015;
Shattock et al., 2015) as well as by less stable than other Na,K-
ATPase isozymes integration into the lipid membranes (Lifshitz
et al., 2007; Kapri-Pardes et al., 2011).
INTERACTIONS BETWEEN Na,K-ATPase
AND NICOTINIC ACETYLCHOLINE
RECEPTOR
Inhibition of the Na,K-ATPase activity has profound effects
on synaptic function associated with nerve endings membrane
depolarization that stimulates release of neurotransmitters
(Lichtstein and Rosen, 2001; Reich et al., 2004; Richards et al.,
2007; Gulledge et al., 2013). However, it has recently become clear
that the Na,K-ATPase functionally and molecularly interacts
with a number of proteins and lipids to modulate synaptic,
neuronal, and other cellular functions (Khatri and Man, 2013;
Reinhard et al., 2013; Cornelius et al., 2015). Na,K-ATPase has
been demonstrated to interact with dopamine (Hazelwood et al.,
2008), AMPA (Zhang et al., 2009), δ-opioid (Deng et al., 2009),
and adenosine A2A (Matos et al., 2013) receptors. Moreover,
functional interactions with glutamate transporters controlling
glutamate uptake by astrocytes (Rose et al., 2009; Genda et al.,
2011; Illarionava et al., 2014) and GlyT2 glycine transporter play
an important role in glycinergic neurotransmission control (de
Juan-Sanz et al., 2013).
Both the Na,K-ATPase and the nicotinic acetylcholine
receptor (nAChR) are integral membrane proteins that play
key roles in membrane excitation. A regulatory mechanism,
where the nAChR and the Na,K-ATPase functionally interact
to modulate the membrane potential, was shown in ganglion
neurons (Park et al., 2010) and in skeletal muscles (Henning et al.,
1994; Kragenbrink et al., 1996; Krivoi et al., 2003, 2006; Heiny
et al., 2010). In ganglion neurons, micromolar concentrations
of acetylcholine (ACh) induce fast depolarization through an
activation of the nAChR followed by sustained hyperpolarization
after ACh removal. This afterhyperpolarization is partly enabled
by increase in Na+ entry which activates the Na,K-ATPase in
concentration-dependent manner. It has been suggested that this
afterhyperpolarization attenuates the firing rate of post-synaptic
neurons acting as an auto-regulatory mechanism for neurons
excitability (Park et al., 2010).
The nAChR oscillates between resting (micromolar affinity
for agonist), open or desensitized (non-conducting state with
nanomolar apparent affinity for agonist) conformations (Prince
and Sine, 1999; Mourot et al., 2006). High concentrations of ACh
promote channel opening following by spontaneous transitions
into the desensitized state. Desensitization can also occur without
channel opening and is favored by prolonged exposure to low
concentrations of agonist. In skeletal muscle, specific binding of
nicotinic agonists to the nAChR stimulates electrogenic transport
by the Na,K-ATPase causing membrane hyperpolarization. An
essential role of the α2 isozyme in this response has been
identified (Krivoi et al., 2003, 2006; Heiny et al., 2010). In contrast
to ganglion neurons, this effect was induced by nanomolar
concentrations of nicotinic agonists (K0.5 ∼ 30 nM for ACh)
(Krivoi et al., 2006). Importantly, stimulation of the Na,K-
ATPase activity did not require ion current through the open
nAChR (Heiny et al., 2010). It can be induced by the nAChR
desensitization alone in the absence of nicotinic agonist and
reaches saturation when the nAChR is fully desensitized. Thus,
the Na,K-ATPase activationmay be triggered by non-competitive
blockers of the nAChR, e.g., proadifen and QX-222, which
promotes the desensitized states, and suppressed by tetracaine
that stabilizes resting conformation of the nAChR (Heiny et al.,
2010).
The nAChR/Na,K-ATPase interaction was demonstrated in
a purified membrane preparation from Torpedo californica,
enriched by the nAChRs and the Na,K-ATPase (Krivoi et al.,
2006; Heiny et al., 2010). This preparation lacks transmembrane
ionic gradients and many modulatory/associative proteins and
factors presented in the intact cell. It was shown that binding
of nanomolar concentrations of ouabain to the Na,K-ATPase
modulates specific ligand interaction with the nAChR, and
vice versa, suggesting a reciprocal modulation between these
two proteins (Krivoi et al., 2006). Additionally, ouabain-
induced conformational changes of the Na,K-ATPase enhance
conformational transition of the nAChR into a desensitized
state (Heiny et al., 2010). Accordingly, these findings suggest a
mechanism by which the nAChR (in desensitized state) interacts
with the Na,K-ATPase and stimulates its pumping activity. Taken
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FIGURE 2 | A hypothetic scheme of the functional interaction between
the nAChR and the α2 Na,K-ATPase isozyme that modulate the resting
membrane potential. (A–F) Schematic representation of how the nAChR in
resting (closed), open, or desensitized conformations interacts with the
Na,K-ATPase in E1 (A,C,E) and E2 (B,D,F) conformations. Only the
desensitized state of the nAChR and E2 conformation of the Na,K-ATPase are
capable interact functionally with each other (F).
into account that the binding of ouabain stabilizes the enzyme E2
conformation, it can be suggested that this conformation of the
Na,K-ATPase and desensitized state of the nAChR are essential
for the functional interaction between these proteins (Krivoi
et al., 2006; Heiny et al., 2010; Krivoi, 2012; Figure 2).
Interaction between the nAChR and the Na,K-ATPase
is expected to enhance muscle excitation in response to
nanomolar concentrations (up to 50 nM) of non-hydrolyzed
ACh which escaped hydrolysis by acetylcholinesterase, attributed
to ACh released in non-quantal form (Nikolsky et al., 1994;
Vyskocil et al., 2009) and remained in the synaptic cleft after
nerve excitation. These nanomolar concentrations of ACh are
insufficient to trigger any massive opening of the nAChR
channels but it can selectively stimulate the α2 Na,K-ATPase
isozyme leading to hyperpolarization of junctional membrane by
∼2–4 mV (Heiny et al., 2010; Chibalin et al., 2012). Importantly,
this local hyperpolarization keeps junctional membrane at a
slightly more negative potential than extrajunctional regions of
the same muscle fibers. This data suggests a mechanism by
which the interaction between nAChR and α2 Na,K-ATPase
isozyme maintains resting potential at voltage range where the
Na+ channel inactivates slowly. This supports the excitability of
junctional membrane during muscle use (Heiny et al., 2010).
This finding suggested that chronic in vivo exposure to
nicotine, the concentration of which reaches hundreds of
nanomoles during tobacco smoking (Benowitz et al., 1997) might
produce long-term effects on the Na,K-ATPase and skeletal
muscle electrogenesis. Experiments on rats chronically (for 21–
31 days) exposed to nicotine delivered orally demonstrated that
nicotine is able to modulate both α1 and α2 isozymes of the
Na,K-ATPase in the diaphragm muscle. The regulatory effects
include both stimulation of the α2 isozyme and inhibition of the
α1 isozyme electrogenic activity leading to the net depolarizing
effect. Increase in the α2 isozyme activity was accompanied with
decrease in its content in the sarcolemma without change in
total homogenate. The same nicotine treatment activated PKC
and increased PLM phosphorylation suggested that cholinergic
modulation of the Na,K-ATPase activity may utilize this
regulatory pathway (Chibalin et al., 2012). Stable reciprocal
interaction between the nAChR of neuronal type and the Na,K-
ATPase was further confirmed in an insect nervous system
(Bao et al., 2015). However, in contrast to skeletal muscle, the
α2 Na,K-ATPase content decreased in homogenates of cerebral
microvessels and brain tissues of rats chronically (for 14 days)
exposed to nicotine using osmotic mini-pumps (Wang et al.,
1994). The reasons of this contradiction are not clear; time-
and use-dependence of chronic nicotine effects as well as high
Ca2+ permeability and other features of neuronal nAChRs can
be proposed.
It is established that the α2 Na,K-ATPase isozyme is enriched
in end-plate membrane where it co-localizes with the nAChRs.
It was also shown that the nAChRs and both α1 and α2 Na,K-
ATPase isozymes co-immunoprecipitate with each other and
with PLM and caveolin-3 (Heiny et al., 2010). Caveolin-3 is
enriched at the neuromuscular junction (NMJ) where it co-
localizes with the nAChR and promotes their clustering in the
end-plate membrane. In congruence, the α subunit of nAChR
has previously been shown to have a putative caveolin-binding
motif (Hezel et al., 2010). Moreover, the caveolin/Na,K-ATPase
interactions are also well-documented (Wang et al., 2004; Morrill
et al., 2012). Since caveolin-3 is associated with caveolae in
fully differentiated skeletal muscles (Galbiati et al., 2001) it
suggests that the nAChR/α2 Na,K-ATPase interaction localizes
in caveolae (Heiny et al., 2010). This spatially restricted complex
is implemented by either direct protein-protein interaction or
via additional adaptive molecular partners including lipids in
the cholesterol-rich membrane microdomains, i.e., lipid rafts and
caveolae. Direct molecular interactions between cholesterol and
membrane receptors are shown. The role of cholesterol-rich lipid
rafts as a signaling platform for the nAChRs clustering is well-
established (Willmann et al., 2006; Zhu et al., 2006; Brannigan
et al., 2010; Levitan et al., 2014). On the other hand, cholesterol
plays an essential role in regulation of the Na,K-ATPase
(Cornelius, 2008; Chen et al., 2009, 2011; Cornelius et al., 2015).
It was recently shown that cholesterol chelating agent, methyl-
β-cyclodextrin, eliminates local hyperpolarization of junctional
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membrane in rat diaphragmmuscles through a selective decrease
in the α2 Na,K-ATPase isozyme electrogenic activity (Kravtsova
et al., 2015b). This data suggests the involvement of cholesterol in
formation and function of the nAChR/α2 Na,K-ATPase complex.
Dystrophin is a cytoskeletal protein that localizes around
entire sarcolemma membrane and provides scaffolding essential
for stabilization of the nAChR clusters in the NMJ. Mice lacking
dystrophin (i.e., X chromosome-linked mouse mutant, MDX)
causes disruption of the NMJ and de-clustering of the nAChRs
(Ghedini et al., 2008; Banks et al., 2009) as well as depolarization
of plasma membrane due to loss of the Na,K-ATPase activity
(Miles et al., 2011). The specific involvement of the α2 Na,K-
ATPase isozyme in these changes has been suggested (Kravtsova
et al., 2010). However, the participation of dystrophin and other
potential molecular partners, such as spectrins and ankyrins
(Williams et al., 2001; Lencesova et al., 2004; Mohler et al.,
2005; Doi and Iwasaki, 2008) in the formation of the nAChR/α2
Na,K-ATPase complex remains to be elucidated.
CARDIOTONIC STEROIDS AND CELL
SURVIVAL
Several reports suggest that endogenous ouabain or ouabain-
like compound changes the activity of α2 or α3 Na,K-ATPase
isozymes that modulates glial and neuronal functions (Song et al.,
2013) and may be involved in mood disorders (Lichtstein and
Rosen, 2001; Goldstein et al., 2006, 2011). In addition, upon
ouabain binding the Na,K-ATPase interacts with neighboring
molecular environment to downstream a number of signaling
intracellular pathways (Xie and Askari, 2002; Aperia, 2007; Li
and Xie, 2009; Fontana et al., 2013; Reinhard et al., 2013).
In different cell types, ouabain has dual effects to promote
programmed cell death (Xiao et al., 2002; Kulikov et al., 2007;
Blanco and Venugopal, 2016) and to protect against apoptosis
(Isaev et al., 2000; Dvela et al., 2012). Nanomolar ouabain
concentrations were also shown to stimulate viability and
proliferation of NT2 cells, precursors for human neuronal cells,
by a mechanism involving Erk1/2 activation (Dvela et al., 2012).
Chronic intraperitoneal administration of low doses of ouabain
significantly improves functional recovery following traumatic
mouse brain injury (Dvela-Levitt et al., 2014).
Functional dysregulation of neuronal metabolism resulting
from over-activation of glutamate receptors (GluRs) leads to
neuronal death and underlies a variety of central nervous
system disorders including stroke, neurodegenerative diseases,
and spinal cord and brain injuries. The excitotoxic stress
response starts with a free intracellular Ca2+ overload which is
the most important of apoptosis (Khodorov, 2004). A similar
mechanism of neuronal dysfunction and cell apoptosis is induced
by micromolar ouabain (Kulikov et al., 2007; Bolshakov et al.,
2012). However, some animal experimental studies have shown
that low-doses of CTS provide neuroprotection against ischemia
(Wang et al., 2006; Oselkin et al., 2010). This anti-apoptotic
action of low ouabain was described when kainic acid and
ouabain were injected into the rat brain in vivo (Golden and
Martin, 2006).
FIGURE 3 | Na,K-ATPase functionally interacts with the plasma
membrane NCX to prevent Ca2+ overload and neuronal apoptosis
during excitotoxic stress. (A) NMDA activates presynaptic and postsynaptic
NMDA receptors resulted in intense Ca2+ entry and intracellular accumulation.
(B) Ouabain binding to Na,K-ATPase modulates the NCX that accelerates
Ca2+ extrusion and prevents neurons from Ca2+ overload. AMPA/KAR,
AMPA and kainic acid receptors; AWCE, alternative to GluRs ways of
Ca2+entry; NKA, Na,K-ATPase. Modified from Sibarov et al. (2012).
Recently it was shown that ouabain at subnanomolar
concentrations can prevent GluR agonist-induced apoptosis in
primary culture of rat cortical neurons (Bolshakov et al., 2012;
Sibarov et al., 2012). Apoptotic injury was prevented when
the agonists were applied together with 0.1–1 nM ouabain
resulting in survival of neurons in this model of excitotoxicity.
Accordingly, ouabain modulated the level of anti-apoptotic
protein Bcl-2, an important regulator of mitochondrial function
and energy metabolism, involved in many vital cell processes
(Zheng et al., 2015). Similar anti-apoptotic effects of low
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ouabain doses have been shown to be associated with enhanced
production of Bcl-2 in in vivo rat model for neurodegeneration
(Golden and Martin, 2006). In cultured rat cortical neurons
ouabain also prevented the increase in frequency of spontaneous
excitatory postsynaptic current and the intracellular Ca2+
overload induced by 240-min exposure to 30 µM N-methyl-D-
aspartate (NMDA). These effects were absent in the presence
of KB-R7943, the plasma membrane NCX inhibitor (Sibarov
et al., 2012). In addition, the postsynaptic epileptiform currents,
reflecting periodical asynchronous glutamate release associated
with elevations in intracellular Ca2+ concentration, were found
to be suppressed by 1 nM ouabain (Sibarov et al., 2014). Ouabain
was, however, found to have a bimodal effect; including anti-
apoptotic action in excitotoxic stress in the concentration range
from 0.1 to 1 nM, and toxic action at concentrations 10 nM–30
µM (Bolshakov et al., 2012).
It was suggested (Sibarov et al., 2012) that during excitotoxic
insults ouabain accelerates Ca2+ extrusion from neurons via
functional interaction between the Na,K-ATPase and the NCX
(Figure 3). Since ouabain inhibits neuronal α3 Na,K-ATPase
isozyme in rats at concentrations that exceed those having anti-
apoptotic effects (i.e., 0.1–1 nM) (Richards et al., 2007) it can be
suggested that this neuroprotective effect takes place via signaling
pathways and does not directly depend on ion translocation by
the Na,K-ATPase (Sibarov et al., 2012). Accordingly, circulating
endogenous ouabain concentration in rat blood plasma and
cerebrospinal fluid varies between 0.1 and 0.74 nM (Dobretsov
and Stimers, 2005). This signaling hypothesis has been further
supported by a demonstration in the crystal structure of
Na,K-ATPase in high-affinity binding state for ouabain with
equilibrium dissociation constant of∼1 nM (Ogawa et al., 2009).
Taken together this data suggests the novel function of the Na,K-
ATPase as a neuroprotective molecule that triggers signaling
pathways upon binding of endogenous ouabain or ouabain-like
compounds by highly conserved binding site.
Finally, neuroprotective effects of exogenous CTS were
shown in vivo (Golden and Martin, 2006; Wang et al., 2006;
Oselkin et al., 2010). However, if endogenous CTS are already
neuroprotective, then exogenously administered ouabain should
have no additional effect. This opens interesting and provocative
question whether the neuroprotective effects of endogenous CTS
are not saturated at physiological conditions due to different
properties compared to exogenous analogs. An alternative
explanation suggests that different regulatory pathways are
triggered and the neuroprotective effects of endogenous and
exogenous CTS are not additive.
CONCLUDING REMARKS
The importance of Na,K-ATPase in various cell functions
recently received new attention. It became clear that the
functional role of the Na,K-ATPase can only be considered
in a complex environment at the subcellular, cellular and
multicellular levels where the Na,K-ATPase is structurally and
functionally linked to other membrane transporters, cytoskeleton
proteins and signaling molecules. We are currently only at
the beginning of our understanding of these complexities.
Future studies of these signalosomes, organized around specific
isozymes of the Na,K-ATPase, will lead to a conceptually new
view on cell physiology and will provide novel targets in
treatment of several life-threatening diseases, e.g., psychiatric
diseases, hypertension, and heart failure.
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